This year, I have been awed by the strength of our community. I think 2014 will be known as the year we effected change at every turn in clinical trials, on Capitol Hill, at the FDA, in doctors’ offices. And we did it as a community. Now it’s time to tackle the next challenge.…Continue
Did you miss our webinar earlier this week? Click below to watch the full presentation and learn more about PPMD’s combination therapies initiative. #givestrength
On Wednesday, December 17th PPMD held a webinar to discuss the therapies that we’re supporting through our year-end campaign. Our speakers provided an overvi...
Early next year, we plan to fund a group of research projects that, together, we believe will help us take a big step forward in ending Duchenne. We need to raise $400,000 before year-end to make that funding possible. The time is now to push that progress forward in a big way. Donate today and your gift will be doubled by a generous match! #givestrengthSee More
PPMD is excited to announce a collaboration with Solid Ventures (Solid) to engage SRI International in the research and development of the “Solid Suit,” a soft, wearable assistive device for people with Duchenne. The Solid Suit idea evolved from pioneering SRI robotics technology originally designed to offset muscle fatigue and augment muscle strength. PPMD and Solid hope the Solid Suit will enable people with Duchenne to one day use a device in their day-to-day activities that…See More
We're hosting a webinar today at 1PM EST to discuss the therapies that we’re supporting through our year-end campaign. We hope you’ll join us!
PPMD is hosting a webinar on Wednesday, December 17th at 1PM to discuss combination therapies, a group of research projects that, together, we believe will hel…
We are enthusiastic about the potential for myostatin inhibitors to stimulate increases in muscle mass and strength for people living with Duchenne. This approach could potentially add an important angle in our fight against this disease and we are pleased to see the time and great care that Pfizer has expended on its development. Our Duchenne community is proud to have the extraordinary passion and expertise of the Pfizer team fighting with us!…See More
The Senate has passed the ABLE Act! Now to the President to be Signed into Law! Thanks to all members of the PPMD community who reached out to your elected officials to help make this day possible! Watch for more details about ABLE Act implementation through PPMD's community site and Facebook page as they become available in early 2015. Learn more about the significance of the ABLE Act for the #Duchenne community:…See More